Medtronic backs Pulnovo Medical in $100m round to expand PADN in pulmonary hypertension
Pulnovo Medical raised $100 million with Medtronic backing. Read what it means for PADN, pulmonary hypertension, heart failure, and device markets.
What FDA breakthrough status for the Amplifi Vein Dilation System means for dialysis care in 2026
Amplifi Vascular’s device earns FDA Breakthrough and CMS Category B status. Find out what this means for dialysis access innovation and payer alignment.
Spiderwort Biotechnologies’ cellulose scaffolds show promise in spinal cord repair
Spiderwort’s spinal cord scaffold earns scientific validation as its dermal filler enters human trials Spiderwort Biotechnologies Inc. has reported two key developments in its cellulose-based regenerative platform, signaling a step forward in both neurorepair and aesthetic medicine. A peer-reviewed study published in Scientific Reports confirms that the company’s plant-derived scaffolds promote neural tissue repair and […]